Venture Fund Xi L.P. Atlas's Net Worth
Venture Fund Xi L.P. Atlas's net worth is estimated to be at least $20,248,164.05 as of 05/02/2024. CoreStreet's estimation of Venture Fund Xi L.P. Atlas's net worth is based on their sale of stock and current holding of stock.
Venture Fund Xi L.P. Atlas is Major Shareholder at Dyne Therapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 154,674 units of DYN stock on 02/28/2024. Their biggest sale was on 02/26/2024 when they sold 201,095 units of Dyne Therapeutics Inc stock for $4,769,973.40. They typically trade 4 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $20,248,164.05
Most recent insider trade:
- Feb. 28, 2024
Venture Fund Xi L.P. Atlas's Insider Trading History
| Dyne Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 28, 2024 | Major Shareholder | 154,674 | $24.84 | Sell | $3,842,102.16 |
Feb. 26, 2024 | Major Shareholder | 201,095 | $23.72 | Sell | $4,769,973.40 |
Feb. 23, 2024 | Major Shareholder | 159,542 | $22.70 | Sell | $3,621,603.40 |
Feb. 21, 2024 | Major Shareholder | 184,501 | $22.57 | Sell | $4,164,187.57 |
Feb. 16, 2024 | Major Shareholder | 162,707 | $23.14 | Sell | $3,765,039.98 |
| Xilio Development Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 8, 2024 | Major Shareholder | 733 | $0.64 | Sell | $469.12 |
Jan. 11, 2024 | Major Shareholder | 1,566 | $0.87 | Sell | $1,362.42 |
| Ikena Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 14, 2021 | Major Shareholder | 5,959 | $14.00 | Sell | $83,426.00 |